Group Effect in Full Replicate Design [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2018-09-12 17:31 (2839 d 02:01 ago) – Posting: # 19278
Views: 10,498

Hi GM,

❝ ❝ For the ABE part (if swR <0.294) like the FDA’s Model II:



❝ But as per Progesterone Guidance, Treatment as random term in Average BE.


No way.

❝ Please see model SAS code from guidance.


MODEL LAUCT = SEQ PER TRT/ DDFM=SATTERTH;

❝ RANDOM TRT/TYPE=FA0(2) SUB=SUBJ G;


Please make yourself familiar with the syntax of SAS’ PROC MIXED. Terms in the MODEL argument are fixed.

❝ As per your version, Subject (nested within Group × Sequence) is the random term.


❝ Now am Confused:ponder:,Which is the correct one?


Mine. For the exact setup ask a qualified SAS-coder.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
151 visitors (0 registered, 151 guests [including 37 identified bots]).
Forum time: 19:32 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5